Stem Cell therapy in IschEmic Non-treatable Cardiac diseasE (SCIENCE)

Projektinformationen

SCIENCE

ID Finanzhilfevereinbarung: 643478

DOI

10.3030/643478

Projekt abgeschlossen

EK-Unterschriftsdatum 3 Dezember 2014

Startdatum 1 Januar 2015

Enddatum 31 Dezember 2020

Finanziert unter

• SOCIETAL CHALLENGES - Health, demographic change and well-being

Gesamtkosten

€ 5 998 882,00

EU-Beitrag

€ 5 998 882,00

Koordiniert durch

REGION HOVEDSTADEN
Denmark

CORDIS bietet Links zu öffentlichen Ergebnissen und Veröffentlichungen von HORIZONT-Projekten.

Links zu Ergebnissen und Veröffentlichungen von RP7-Projekten sowie Links zu einigen Typen spezifischer Ergebnisse wie Datensätzen und Software werden dynamisch von OpenAIRE abgerufen.

Leistungen

Other (4)

First patient treated

First patient treated.

IMP production final

Production of IMP for clinical trial final.

Clinical trial kick-off

Clinical Trial Kick-off meeting with all clinical partners.

International workshop

Arrangements for an international scientific workshop on stem cell-based treatment of cardiac disease.

Documents, reports (13)

Monitoring of clinical sites

Monitoring of clinical sites.

Status on posting of results

Report on the status of the posting of results (to the study registry).

Training logs

Training logs for personnel complete

Quantification of cardiac fibrosis

A clinically applicable technique to determine and quantify cardiac fibrosis by MRI

Determination of local deformation parameters

Easy to use protocol for 3D echocardiography to determine local deformation parameters. Use the local myocardial deformation to assess the local effects of cardiac regenerative therapy on local cardiac function

Comprehensive cost-PU effectiveness

Comprehensive cost-PU effectiveness: Using country comparisons results and refinement of methods, a conclusive assessment of the economic effects of ASC therapy can be given.

Planning tool for cardiac cell therapy

Validation of a novel treatment planning tool for cardiac cell therapy, that is based on real time image integration

IP management

IP management final.

Dissemination

Dissemination to relevant groups and meetings. Production technology published in peer reviewed journal. Clinical trial design published in peer reviewed journal.

Preliminary cost-effectiveness analysis

First preliminary results of health economics: Standard cost-effectiveness analysis of ASC therapy for each country involved, analysis of country differences

All approvals package

All approvals from national ethics committees and national competent authorities of all study sites recieved.

Method for a financial analysis

Developed tools: A methodology for a financial analysis of innovative medical technology will be set up comprising a software tool to be used on the spot by the developers of the technologies

Qualification of production facility

Documentation of proper classification for sterile GMP production.

Demonstrators, pilots, prototypes (2)

Production initiated

Production ready to start.

Clinical databases

IWRS, eCRF and database developed

Websites, patent fillings, videos etc. (1)

Website

Establishment of SCIENCE website for public and partner use.

Veröffentlichungen

Peer reviewed articles (4)

Intracoronary autologous bone marrow cell transfer after acute myocardial infarction: abort and refocus

Autoren: Jozef Bartunek, Wojtek Wojakowski
Veröffentlicht in: European Heart Journal, Ausgabe 38/39, 2017, Seite(n) 2944-2947, ISSN 0195-668X
Herausgeber: Oxford University Press
DOI: 10.1093/eurheartj/ehx300

Global position paper on cardiovascular regenerative medicine

Autoren: Francisco Fernández-Avilés, Ricardo Sanz-Ruiz, Andreu M. Climent, Lina Badimon, Roberto Bolli, Dominique Charron, Valentin Fuster, Stefan Janssens, Jens Kastrup, Hyo-Soo Kim, Thomas F. Lüscher, John F. Martin, Philippe Menasché, Robert D. Simari, Gregg W. Stone, Andre Terzic, James T. Willerson, Joseph C. Wu, Francisco Fernández-Avilés, Andre Terzic, Lina Badimon, Kathleen Broughton, Darcy L
Veröffentlicht in: European Heart Journal, Ausgabe 38/33, 2017, Seite(n) 2532-2546, ISSN 0195-668X
Herausgeber: Oxford University Press
DOI: 10.1093/eurheartj/ehx248

Rationale and design of the European multicentre study on Stem Cell therapy in IschEmic Non-treatable Cardiac diseasE (SCIENCE)

Autoren: Christina Paitazoglou, Martin W. Bergmann, Bojan Vrtovec, Steven A.J. Chamuleau, Bas van Klarenbosch, Wojtek Wojakowski, Aleksandra Michalewska-Włudarczyk, Mariann Gyöngyösi, Annette Ekblond, Mandana Haack-Sørensen, Kai Jaquet, Karsten Vrangbaek, Jens Kastrup
Veröffentlicht in: European Journal of Heart Failure, 2019, ISSN 1388-9842
Herausgeber: Elsevier BV
DOI: 10.1002/ejhf.1412

Global Overview of the Transnational Alliance for Regenerative Therapies in Cardiovascular Syndromes (TACTICS) Recommendations

Autoren: Francisco Fernández-Avilés, Ricardo Sanz-Ruiz, Andreu M. Climent, Lina Badimon, Roberto Bolli, Dominique Charron, Valentin Fuster, Stefan Janssens, Jens Kastrup, Hyo-Soo Kim, Thomas F. Lüscher, John F. Martin, Philippe Menasché, Fausto J. Pinto, Robert D. Simari, Gregg W. Stone, Andre Terzic, James T. Willerson, Joseph C. Wu
Veröffentlicht in: Circulation Research, Ausgabe 122/2, 2018, Seite(n) 199-201, ISSN 0009-7330
Herausgeber: Lippincott Williams & Wilkins Ltd.
DOI: 10.1161/circresaha.117.312099

Rechte des geistigen Eigentums

Patent (1)

STEM CELL THERAPY BASED ON ADIPOSE-DERIVED STEM CELLS

Antrags-/Publikationsnummer: 20 16075407
Datum: 2016-10-21
Antragsteller: REGION HOVEDSTADEN